COVID 19 antibody test | sciencenewsnet.in

Breaking News

At the Roots of Business Ethics: A New Reading of the Merchant of Venice

Digital Science Teams Up with Huron to Strengthen Research Security and Compliance for Education and Research Clients

American Thyroid Association® Announces 2024-2025 Officers and Board of Directors

Diabetes Drug Appears to Fight Lung Cancer — But Only in Overweight or Obese Patients

Don’t Rock the Boat: The Social-symbolic Work to Confront Ethnic Discrimination in Branches of Professional Service Firms

Virtual replicas for real-world solutions: digital twins in action

Beyond lithium: the rise of sustainable battery alternatives

Novel Gene Therapy Trial for Sickle Cell Disease Launches

Behind the Model: Science Inspired by Legos

Quantifying disease impact and overcoming practical treatment barriers for primary progressive aphasia

26 Nov, 2024

New study finds reinfection by SARS-CoV-2 in healthy young adults is common

February 1, 2021 sarah JonasResearch Alert

MEDIA ADVISORY Paper title: SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study Corresponding Author: Stuart C. Sealfon, MD, Professor of Neurology, Neuroscience and Pharmacological Sciences, Icahn School of Medicine at Mount Sinai Bottom Line: Although…

Baylor Scott & White Health Enrolls First Patients in the World in Trial for Inhaled Remdesivir

October 2, 2020 sarah JonasFeature

Earlier this month, Baylor Scott & White Research Institute enrolled the first four patients in the world on Gilead’s new clinical trial involving an investigational inhaled solution of remdesivir (NCT04539262). This is Gilead’s first trial in COVID-19 patients examining the safety and efficacy of an inhaled solution of the drug in an outpatient setting. The study of an inhaled solution asks whether this mode of delivery can help reduce the amount of virus from the airways earlier.